Akero Therapeutics

Home » Akero Therapeutics

IPO

Akero Therapeutics

Biotechnology

We are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.

Symbol

AKRO

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
June 20, 2019

Underwriters
J.P. MORGAN SECURITIES LLC,ROTH CAPITAL PARTNERS, LLC

This offering is no longer available

To view the prospectus for Akero Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253